nach oben

Cancer Causes & Control

Erschienen in:

01.08.2012 | Original Paper

Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992–2009

verfasst von: Tonia Forte, Jin Niu, Gina A. Lockwood, Heather E. Bryant

Erschienen in: Cancer Causes & Control | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Recently, human papillomavirus (HPV) infection has been causally associated with a subset of head and neck cancers, particularly oropharyngeal cancer. As national cancer reporting systems typically report incidence rates of oropharyngeal cancer grouped with other cancers of the head and neck region, the objective of this study was to present age-standardized incidence trends in oropharyngeal cancer Canada-wide.

Methods

Data were obtained from the Canadian Cancer Registry for cases diagnosed between 1992 and 2009. Trends in age-standardized incidence rates were described for head and neck cancers overall and for HPV-associated oropharyngeal cancer using Joinpoint regression.

Results

The age-standardized incidence of head and neck cancers declined significantly in Canada from 1992 to 1998 (annual percentage change [APC] = −3.0, p < 0.01), then remained stable through to 2009. In contrast, the age-standardized incidence of HPV-associated oropharyngeal cancer increased significantly during the same time period, from 1.6 per 100,000 in 1992 to 2.6 in 2009 (APC = 2.7, p < 0.001). The increase in HPV-associated oropharyngeal cancer was greater in males than in females and increased significantly in all age groups, particularly those aged 50–59 (APC = 5.4, p < 0.001). The age-standardized incidence rate of head and neck cancer overall was stable or declined in all age groups except those aged 50–59 where incidence decreased from 1992 to 1997, then increased through to 2009.

Conclusions

The incidence patterns of HPV-associated oropharyngeal cancer and head and neck cancer overall show contrasting trends. Findings highlight the need to surveil HPV-associated oropharyngeal cancer separately from other cancers of the head and neck region in order to monitor these emerging trends.

Canadian Cancer Society’s Steering Committee on Cancer Statistics (2011) Canadian cancer statistics 2011. Canadian Cancer Society, Toronto

Reid JL, Hammond D (2009) Tobacco use in Canada: patterns and trends, 2009, v2 edn. Propel Centre for Population Health Impact, University of Waterloo, Waterloo, ON

Parkin DM, Bray F (2006) Chapter 2: the burden of HPV-related cancers. Vaccine 24(Suppl 3):11–25CrossRef

Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J (1983) Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12(6):418–424PubMedCrossRef

Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ et al (1992) Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 51(6):845–850PubMedCrossRef

Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T, Anagnostopoulos I et al (1990) Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol 43(11):918–921PubMedCrossRef

Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709–720PubMedCrossRef

Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14(2):467–475PubMedCrossRef

Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P et al (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344(15):1125–1131PubMedCrossRef

10.

D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM et al (2007) Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356(19):1944–1956PubMedCrossRef

11.

Pintos J, Black MJ, Sadeghi N, Ghadirian P, Zeitouni AG, Viscidi RP et al (2008) Human papillomavirus infection and oral cancer: a case–control study in Montreal, Canada. Oral Oncol 44(3):242–250PubMedCrossRef

12.

IARC (2007) IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses, vol 90. IARC, Lyon

13.

Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26(4):612–619PubMedCrossRef

14.

Syrjanen S (2004) HPV infections and tonsillar carcinoma. J Clin Pathol 57(5):449–455PubMedCrossRef

15.

Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ (2000) Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 11(6):489–495PubMedCrossRef

16.

Shiboski CH, Schmidt BL, Jordan RC (2005) Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer 103(9):1843–1849PubMedCrossRef

17.

Robinson KL, Macfarlane GJ (2003) Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing? Oral Oncol 39(1):31–36PubMedCrossRef

18.

Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J et al (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119(11):2620–2623PubMedCrossRef

19.

Conway DI, Stockton DL, Warnakulasuriya KA, Ogden G, Macpherson LM (2006) Incidence of oral and oropharyngeal cancer in United Kingdom (1990–1999)—recent trends and regional variation. Oral Oncol 42(6):586–592PubMedCrossRef

20.

Braakhuis BJ, Visser O, Leemans CR (2009) Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol 45(9):e85–e89PubMedCrossRef

21.

Hocking JS, Stein A, Conway EL, Regan D, Grulich A, Law M et al (2011) Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104(5):886–891PubMedCrossRef

22.

Auluck A, Hislop G, Bajdik C, Poh C, Zhang L, Rosin M (2010) Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 116(11):2635–2644PubMed

23.

Cancer Care Ontario (2011) HPV-related oral cancers increasing among Ontario men 2011 Contract no.: July 2011

24.

Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W et al (2010) SEER cancer statistics review 1975–2008. National Cancer Institute, Bethesda; available from: http://seer.cancer.gov/csr/1975_2008/

25.

Cancer Research UK (2011) CancerStats—cancer statistics for the UK. London; available from: http://info.cancerresearchuk.org/cancerstats/

26.

Ferlay J, Shin HR, Bray F, Forman D, C M, Parkin DM (2010) GLOBOCAN 1: cancer incidence and mortality worldwide: IARC CancerBase no. 10. International Agency for Research on Cancer, France; available from: http://globocan.iarc.fr

27.

Statistics Canada (2012) Canadian Cancer Registry (CCR). Statistics Canada, Ottawa; available from: http://www23.statcan.gc.ca:81/imdb/p2SV.pl?Function=getSurvey&SDDS=3207#a3

28.

Ernster JA, Sciotto CG, O’Brien MM, Finch JL, Robinson LJ, Willson T et al (2007) Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 117(12):2115–2128PubMedCrossRef

29.

Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301

30.

Turner CF, Danella RD, Rogers SM (1995) Sexual behavior in the United States 1930–1990: trends and methodological problems. Sex Transm Dis 22(3):173–190PubMedCrossRef

31.

Smith T (1998) American sexual behavior: trends, socio-demographic differences, and risk behavior. Report no. 25. University of Chicago, Chicago

32.

Rosenquist K, Wennerberg J, Schildt EB, Bladstrom A, Goran Hansson B, Andersson G (2005) Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case–control study in southern Sweden. Acta Otolaryngol 125(12):1327–1336PubMedCrossRef

33.

Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan’gina O et al (2010) Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 39(1):166–181PubMedCrossRef

34.

Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D et al (2004) Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108(5):766–772PubMedCrossRef

35.

Marur S, D’Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11(8):781–789PubMedCrossRef

36.

Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E (2000) Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89(3):300–304PubMedCrossRef

37.

Lindquist D, Romanitan M, Hammarstedt L, Nasman A, Dahlstrand H, Lindholm J et al (2007) Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 1(3):350–355PubMedCrossRef

38.

Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35PubMedCrossRef

39.

Gillison ML, D’Souza G, Westra W, Sugar E, Xiao W, Begum S et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100(6):407–420PubMedCrossRef

40.

Public Health Agency of Canada (2007) National Advisory Committee on Immunization (NACI) statement on humanpapillomavirus vaccine. Public Health Agency of Canada, Ottawa

Titel: Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992–2009
verfasst von: Tonia Forte
Jin Niu
Gina A. Lockwood
Heather E. Bryant
Publikationsdatum: 01.08.2012
Verlag: Springer Netherlands
Erschienen in: Cancer Causes & Control / Ausgabe 8/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-012-0013-z

Springer Medizin

Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992–2009

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2012

Plasma total, LDL, and HDL cholesterol and risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort

The association between cigarette smoking and non-Hodgkin lymphoid neoplasms in a large US cohort study

Comparison of breast and cervical cancer screening utilization among rural and urban Hispanic and American Indian women in the Southwestern United States

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort

Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case–control study

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie